[1] Scalone G, Niccoli G.A focus on the prognosis and management of ischemic heart disease in patients without evidence of obstructive coronary artery disease[J]. Expert Rev Cardiovasc Ther, 2015,13(9):1031-1044.
[2] Jennings RB.Historical perspective on the pathology of myocardial ischemia/reperfusion injury[J]. Circ Res, 2013,113(4):428-438.
[3] Lagos-Quintana M, Rauhut R, Yalcin A, et al.Identification of tissue-specific microRNAs from mouse[J]. Current Biol, 2002, 12(9):735-739.
[4] Lewis BP, Burge CB, Bartel DP.Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J]. Cell, 2005,120(1):15-20.
[5] Zampetaki A, Dudek K, Mayr M.Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling[J]. Free Radic Biol Med, 2013, 64:69-77.
[6] Meloni M, Marchetti M, Garner K, et al.Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction[J]. Mol Ther, 2013, 21(7):1390-1402.
[7] Qin Y, Yu Y, Dong H, et al.MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis[J]. Int J Med Sci, 2012, 9(6):413-423.
[8] Tijsen AJ, Pinto YM, Creemers EE.Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases[J]. Am J Physiol Heart Circ Physiol, 2012, 303(9):H1085-1095.
[9] Cortez MA, Calin GA.MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases[J]. Expert Opin Biol Ther, 2009, 9(6):703-711.
[10] Kroh EM, Parkin RK, Mitchell PS, et al.Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)[J]. Methods, 2010, 50(4): 298-301.
[11] Wang X, Zhang X, Ren XP, et al.MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury[J]. Circulation, 2010, 122(13): 1308-1318.
[12] Pan Z, Sun X, Ren J, et al.miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models[J]. PloS One, 2012, 7(11): e50515.
[13] Ren XP, Wu J, Wang X, et al.MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20[J]. Circulation, 2009, 119(17): 2357-2366.
[14] Murry CE, Jennings RB, Reimer KA.Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[J]. Circulation, 1986, 74(5): 1124-1136.
[15] Ye JX, Chen DZ.Novel cardioprotective strategy combining three different preconditioning methods to prevent ischemia/reperfusion injury in aged hearts in an improved rabbit model[J]. Exp Ther Med, 2015, 10(4): 1339-1347.
[16] Skyschally A, Gent S, Amanakis G, et al.Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways[J]. Circ Res, 2015,117(3):279-288.
[17] Van Wylen DG.Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia[J]. Circulation, 1994, 89(5):2283-2289.
[18] Xiang X, Lin H, Liu J, et al.Equivalent cardioprotection induced by ischemic and hypoxic preconditioning[J]. The Thorac Cardiovas Surg, 2013, 61(3):229-233.
[19] Yamashita N, Hoshida S, Taniguchi N, et al.Whole-body hyperthermia provides biphasic cardioprotection against ischemia/reperfusion injury in the rat[J]. Circulation, 1998, 98(14):1414-1421.
[20] Marber MS, Latchman DS, Walker JM, et al.Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction[J]. Circulation, 1993, 88(3):1264-1272.
[21] Kuzuya T, Hoshida S, Yamashita N, et al.Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia[J]. Circ Res, 1993, 72(6):1293-1299.
[22] Tang XL, Qiu Y, Park SW, et al.Time course of late preconditioning against myocardial stunning in conscious pigs[J]. Circ Res, 1996, 79(3):424-434.
[23] Kim HW, Haider HK, Jiang S, et al.Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2[J]. J Biol Chem, 2009, 284(48):33161-33168.
[24] Eckle T, Köhler D, Lehmann R, et al.Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning[J]. Circulation, 2008, 118(2): 166-175.
[25] Haider KH, Kim HW, Ashraf M.Hypoxia-inducible factor-1alpha in stem cell preconditioning: mechanistic role of hypoxia-related micro-RNAs[J]. J Thorac Cardiovasc Surg, 2009, 138(1):257.
[26] Zhang Y, Zhang L, Chu W, et al.Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes[J]. Cell Physiol Biochem, 2010, 26(6):991-998.
[27] Shan H, Li X, Pan Z, et al.Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1[J]. Br J Pharmacol, 2009, 158(5):1227-1235.
[28] Currie RW, Tanguay RM, Kingma JG, et al.Heatshock response and limitation of tissue necrosis during occlusion reperfusion in rabbit hearts[J]. Circulation, 1993, 87(3):963-971.
[29] Yin C, Wang X, Kukreja RC.Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice[J]. FEBS Letters, 2008, 582(30):4137-4142.
[30] Cai Z, Manalo DJ, Wei G, et al.Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury[J]. Circulation, 2003,108(1):79-85.
[31] Xi L, Tekin D, Gursoy E, et al.Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia[J].Am J Physiol Heart Circ Physiol, 2002, 283(1):H5-12.
[32] Rane S, He M, Sayed D, et al.An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on mir-199a-5p[J]. Cell Signal, 2010, 22(7):1054-1062. |
